Not Medicare Enrolled

Dr. Raj Eliazer, MD

Neurology · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2727 W DR MARTIN LUTHER KING JR BLVD, Tampa, FL 33607
8133211429
In practice since 2005 (20 years)
NPI: 1144210238 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eliazer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eliazer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eliazer

Dr. Raj Eliazer is a neurology in Tampa, FL, with 20 years in practice. Based on federal Medicare data, Dr. Eliazer performed 302 Medicare services across 222 unique beneficiaries.

Between the years covered by Open Payments, Dr. Eliazer received a total of $16,153 from 69 pharmaceutical and/or device companies across 878 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eliazer is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 302 Medicare services$ $16,153 industry payments

Medicare Practice Summary

Medicare Utilization ↗
302
Medicare services
Bottom 35% in FL for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
222
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)164$64$220
Office visit, established patient (10-19 min)81$37$162
Needle measurement of electrical activity in arm or leg muscles, complete study22$104$240
New patient office visit (30-44 min)22$67$277
Office visit, established patient (30-39 min)13$68$313
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,153
Total received (2018-2024)
Avg $2,308/year across 7 years
Top 19% in FL for neurology
69
Companies
878
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,082 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$72 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$76
2023
$2,960
2022
$3,608
2021
$2,580
2020
$2,415
2019
$2,319
2018
$2,195

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,577
Teva Pharmaceuticals USA, Inc.
$1,222
UCB, Inc.
$988
Biogen, Inc.
$904
Amgen Inc.
$831
Sunovion Pharmaceuticals Inc.
$785
GENZYME CORPORATION
$724
Supernus Pharmaceuticals, Inc.
$601
Novartis Pharmaceuticals Corporation
$594
Avanir Pharmaceuticals, Inc.
$512
SK Life Science, Inc.
$473
Biohaven Pharmaceutical Holding Company Ltd.
$453
Lundbeck LLC
$443
Allergan, Inc.
$399
AbbVie Inc.
$349
Lilly USA, LLC
$348
Neurocrine Biosciences, Inc.
$327
ACADIA Pharmaceuticals Inc
$321
Takeda Pharmaceuticals U.S.A., Inc.
$314
EMD Serono, Inc.
$246
Alexion Pharmaceuticals, Inc.
$236
Allergan Inc.
$214
Biohaven Pharmaceuticals, Inc.
$205
Genentech USA, Inc.
$189
Adamas Pharmaceuticals, Inc.
$162
PFIZER INC.
$157
Upsher-Smith Laboratories LLC
$154
Eisai Inc.
$126
Janssen Pharmaceuticals, Inc
$121
JAZZ PHARMACEUTICALS INC.
$115
Neurelis, Inc.
$100
CSL Behring
$99
Horizon Therapeutics plc
$99
Xeris Pharmaceuticals, Inc.
$96
EISAI INC.
$93
AstraZeneca Pharmaceuticals LP
$90
UPSHER-SMITH LABORATORIES LLC
$85
Almatica Pharma LLC
$84
Greenwich Biosciences, Inc.
$83
PORTOLA PHARMACEUTICALS, INC.
$78
Acorda Therapeutics, Inc
$72
GRT US Holding, Inc.
$64
Mitsubishi Tanabe Pharma America, Inc.
$60
SANOFI-AVENTIS U.S. LLC
$60
Sumitomo Pharma America, Inc.
$59
BANNER LIFE SCIENCES, LLC
$58
Bayer HealthCare Pharmaceuticals Inc.
$58
ASSERTIO THERAPEUTICS, Inc.
$57
Banner Life Sciences, LLC
$52
Otsuka America Pharmaceutical, Inc.
$52
PORTOLA PHARMACEUTICALS, LLC
$48
Assertio Therapeutics, Inc.
$45
Amneal Pharmaceuticals LLC
$44
GE HealthCare
$43
E.R. Squibb & Sons, L.L.C.
$42
Impax Laboratories, Inc.
$39
GE HEALTHCARE
$38
Medtronic USA, Inc.
$32
ARBOR PHARMACEUTICALS, INC.
$31
ARGENX US, INC.
$30
Abbott Laboratories
$25
AQUESTIVE THERAPEUTICS, INC.
$25
Vanda Pharmaceuticals Inc.
$22
Sonex Health, Inc.
$21
IMPEL PHARMACEUTICALS INC.
$21
Nevro Corp.
$18
Boston Scientific Corporation
$13
Collegium Pharmaceutical, Inc.
$13
Neuronetics, Inc.
$13
Top 3 companies account for 23.4% of total payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Andexxa · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · COPAXONE · Cambia · DUOPA · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · GVOKE PFS · Gralise · HETLIOZ · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · Kcentra · LEMTRADA · LYRICA · MAYZENT · Mavenclad · NAMZARIC · NEUROSTAR TMS THERAPY · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Ongentys · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SYMPAZAN · Senza · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · ULTRAGUIDECTR · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · WATCHMAN · XCOPRI · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $5,349 per 100 Medicare services performed
Looking for a neurology in Tampa?
Compare neurologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
183
Per 100K population
12.3
County median income
$75,011
Nearest hospital
ST JOSEPHS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Eliazer is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 19%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Eliazer experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Eliazer performed 164 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eliazer receive payments from pharmaceutical companies?
Yes. Dr. Eliazer received a total of $16,153 from 69 companies across 878 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eliazer's costs compare to other neurologys in Tampa?
Dr. Eliazer's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Eliazer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →